Skip to main content

Advertisement

SpringerLink
Log in

Soft Tissue Sarcomas in Children

  • Symposium on Pediatric Oncology : Malignant Solid Tumors
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Pediatric soft tissue sarcomas (STS) are a heterogeneous group of malignant tumors constituting about 7% of all cancer cases. Rhabdomyosarcomas (RMS) constitute about half of all soft tissue sarcomas in children, the rest being constituted by non- rhabdomyosarcoma soft tissue sarcomas (NRSTS). Most RMS present in young children <6 y of age while the NRSTS occur in adolescents and young adults. The latter constitute a diverse group of tumors and are rare in children. The STS generally present as painless enlarging mass or with symptoms of compression/infiltration of adjacent organs or structures. Staging, risk stratification and multidisciplinary approach are needed for the treatment of STS and outcome depends on stage, site and histological type. Treatment of RMS has evolved systematically through various clinical trials. Chemotherapy remains the backbone of treatment for RMS and local control is achieved either with surgery or radiotherapy or both. Management of NRSTS is still a challenge as it is generally chemotherapy-resistant and surgery remains the mainstay of treatment. Outcome therefore depends on whether wide local excision with negative margins is possible. Local radiotherapy is reserved for recurrent, residual and large high grade NRST. The prognosis of metastatic as well as recurrent STS remains dismal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Consolidated Report of Population Based Cancer Registries 2001–2001. National Cancer Registry Programme, Indian Council Medical Research, Bangalore, India, Dec 2006. Available from : http://www.icmr.nic.in/ncrp/report_pop_2001-04/cancer_p_based.htm

  2. First Report of the Population Based Cancer Registries under North Eastern Regional Cancer Registry 2003–2004. National Cancer Registry Programme, Indian Council of Medical Research, Bangalore, India, Sep 2006. Available from: http://www.icmr.nic.in/ncrp/first_report_2003-04/first_report.htm.

  3. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    Article  PubMed  Google Scholar 

  4. Gurney JG, Young JL Jr, Roffers SD, et al. Soft tissue sarcomas. In: Ries LAG, Smith MA, Gurney JG, et al.eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. NIH Pub. No. 99–4649. Bethesda, MD: National Cancer Institute, SEER Program 1999:pp111.

  5. Ries LA, Smith MA, Gurney J, et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, 1999. SEER Program Pub No.99-4649.

  6. McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med. 1995;332:12–8.

    Article  PubMed  CAS  Google Scholar 

  7. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer 2005;103:1457–67.

    Google Scholar 

  8. Mihara S, Matsumoto H, Tokunaga F, Yano H, Ota M, Yamashita S. Botryoid rhabdomyosarcoma of the gallbladder in a child. Cancer. 1982;49:812–8.

    Article  PubMed  CAS  Google Scholar 

  9. Kedar A, Cantrel G, Rosen G. Rhabdomyosarcoma of the trachea. J Laryngol Otol. 1988;102:735–6.

    Article  PubMed  CAS  Google Scholar 

  10. Schmaltz AA, Apitz J. Primary rhabdomyosarcoma of the heart. Pediatr Cardiol. 1982;2:73–5.

    Article  PubMed  CAS  Google Scholar 

  11. Ferrari A, Casanova M, Collini P, et al. Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol. 2005;23:4021–30.

    Article  PubMed  Google Scholar 

  12. Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adult. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg. 1993;217:72–7.

    Article  PubMed  CAS  Google Scholar 

  13. Rikhof B, de Jong S, Suurmeijer AJ, Meijer C, van der Graaf WT. The insulin-like growth factor system and sarcomas. J Pathol. 2009;217:469–82.

    Article  PubMed  CAS  Google Scholar 

  14. Hanukoglu A, Chalew SA, Sun CJ, Dorfman GD, Bright RW. Surgically curable hypophosphatemic rickets. Diagnosis and management. Clin Pediatr. 1989;28:321–5.

    Article  CAS  Google Scholar 

  15. Parham DM, Webber BL, Jenkins 3rd JJ, Cantor AB, Maurer HM. Nonrhabdomyosarcomatous soft tissue sarcomas of childhood: formulation of a simplified system for grading. Mod Pathol. 1995;8:705–10.

    PubMed  CAS  Google Scholar 

  16. Crist W, Gehan EA, Ragab AH, et al. The third intergroup rhabdomyosarcoma study. J Clin Oncol. 1995;13:610–30.

    PubMed  CAS  Google Scholar 

  17. Crist WM, Garnsey L, Beltangady MS, et al. Prognosis in children with rhabdomyosarcoma: a report of the intergroup rhabdomyosarcoma studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol. 1990;8:443–52.

    PubMed  CAS  Google Scholar 

  18. Lawrence W, Gehan E, Hays D, Beltangady M, Maurer H. Prognostic significance of staging factors of the UICC staging system in childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS II). J Clin Oncol. 1987;5:46–54.

    PubMed  Google Scholar 

  19. Lawrence Jr W, Anderson JR, Gehan EA, Maurer H. Pre-treatment TNM staging of childhood rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Cancer. 1997;80:1165–70.

    Article  PubMed  Google Scholar 

  20. Gehan EA, Glover FN, Maurer HM, et al. Prognostic factors in children with rhabdomyosarcoma. Natl Cancer Inst Monogr. 1981;56:83–92.

    PubMed  Google Scholar 

  21. Greene FL, Page DL, Fleming ID, et al. AJCC staging manual. 6th ed. New York: Springer; 2002.

  22. Hajdu SI, Shiu MH, Brennan MF. The role of the pathologist in the management of soft tissue sarcomas. World J Surg. 1988;12:326–31.

    Article  PubMed  CAS  Google Scholar 

  23. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–20.

    PubMed  Google Scholar 

  24. Maurer HM, Beltangady M, Gehan EA, et al. The intergroup rhabdomyosarcoma study-I. A final report Cancer. 1988;61:209–20.

    CAS  Google Scholar 

  25. Maurer HM, Gehan EA, Beltangady M, et al. The intergroup rhabdomyosarcoma study-II. Cancer. 1993;71:1904–22.

    Article  PubMed  CAS  Google Scholar 

  26. Arndt C, Tefft M, Gehan E, et al. A feasibility, toxicity, and early response study of etoposide, ifosfamide, and vincristine for the treatment of children withrhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study (IRS) IV pilot study. J Pediatr Hematol Oncol. 1997;19:124–9.

    Article  PubMed  CAS  Google Scholar 

  27. Ruymann FB, Vietti T, Gehan E, et al. Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response. J Pediatr Hematol Oncol. 1995;17:331–7.

    Article  PubMed  CAS  Google Scholar 

  28. Cecchetto G, Carli M, Sotti G, et al. Importance of local treatment in pediatric soft tissue sarcomas with microscopic residual after primary surgery: results of the Italian Cooperative Study RMS-88. Med Pediatr Oncol. 2000;34:97–101.

    Article  PubMed  CAS  Google Scholar 

  29. Koscielniak E, Klingebiel TH, Peters C, et al. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. Bone Marrow Transplant. 1997;19:227–31.

    Article  PubMed  CAS  Google Scholar 

  30. Stevens MC, Rey A, Bouvet N, et al. Treatment of nonmetastatic rhabdomyosarcomas in childhood and adolescence: third study of the International Society of Paediatric Oncology-SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol. 2005;23:2618–28.

    Article  PubMed  Google Scholar 

  31. Koscielniak E, Harms D, Henze G, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol. 1999;17:3706–19.

    PubMed  CAS  Google Scholar 

  32. Ferrari A, Casanova M. Current chemotherapeutic strategies for rhabdomyosarcoma. Expert Rev Anticancer Ther. 2005;5:283–94.

    Article  PubMed  CAS  Google Scholar 

  33. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 1999;17:3487–93.

    PubMed  CAS  Google Scholar 

  34. Mazzoleni S, Bisogno G, Garaventa A, et al. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer. 2005;104:183–90.

    Article  PubMed  Google Scholar 

  35. Mattke AC, Bailey EJ, Schuck A, et al. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas? Pediatr Blood Cancer. 2009;52:772–6.

    Article  PubMed  Google Scholar 

  36. Van Winkle P, Angiolillo A, Krailo M, et al. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children’s Cancer Group (CCG) experience. Pediatr Blood Cancer. 2005;44:338–47.

    Article  PubMed  Google Scholar 

  37. Cosetti M, Wexler LH, Calleja E, et al. Irinotecan for pediatric solid tumors: the Memorial Sloan-Kettering experience. J Pediatr Hematol Oncol. 2002;24:101–5.

    Article  PubMed  Google Scholar 

  38. Pappo AS, Lyden E, Breitfeld P, et al. Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children’s Oncology Group. J Clin Oncol. 2007;25:362–9.

    Article  PubMed  CAS  Google Scholar 

  39. Pappo AS, Devidas M, Jenkins J, et al. Phase II trial of neoadjuvant vincristine, ifosfamide and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. J Clin Oncol. 2005;23:4031–8.

    Article  PubMed  CAS  Google Scholar 

  40. Bramwell VH, Mouridsen HT, Santoro A, et al. Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma Group. Cancer Chemother Pharmacol. 1993;31(2):S180–4.

    PubMed  Google Scholar 

  41. Bramwell V, Quirt I, Warr D, et al. Combination chemotherapy with doxorubicin, dacarbazine, and ifosfamide in advanced adult soft tissue sarcoma. Canadian Sarcoma Group-National Cancer Institute of Canada Clinical Trials Group. J Natl Cancer Inst. 1989;81:1496–9.

    Article  PubMed  CAS  Google Scholar 

  42. Edmonson JH, Ryan LM, Blum RH, et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993;11:1269–75.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology and Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Sector 5, Rohini, Delhi, 110085, India

    Gauri Kapoor & Kunal Das

Authors
  1. Gauri Kapoor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kunal Das
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gauri Kapoor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapoor, G., Das, K. Soft Tissue Sarcomas in Children. Indian J Pediatr 79, 936–942 (2012). https://doi.org/10.1007/s12098-011-0560-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-011-0560-4

Keywords

Search

Navigation